Trials / Sponsors / Lu Wang, MD, PhD
Lu Wang, MD, PhD
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer Gallbladder Cancer, Initially Unresectable, the First Line Treatment | Phase 2 | 2022-12-22 |
| Unknown | HAIC Combined With Toripalimab and Donafenib for Advanced BTC Biliary Tract Adenocarcinoma | Phase 2 | 2022-03-01 |